Ebrahim S. Delpassand, MD
Founder & Chairman of the Board/ CEO of RadioMedix (2006)
- • Board certified nuclear medicine physician• Former Deputy Chair and Chief of Clinical Nuclear Medicine MD. Anderson Cancer Center• Founder & Chariman of Excel Diagnostics & Nuclear Oncology Center (2003)• PI/Sponsor of current five INDs• Adjunct professor, Department of Radiation Oncology, UT and Nuclear Medicine at BCM inHouston.• Co-Founder of Infinity Care (home healthcare company) and Infinity Infusion Care.• Executed exit strategy for acquisition of Infinity Infusion Care by Curative Healthcare in 2002.
Randy Peterson
MSc., Ph.D., MBA Chief Operating Officer (COO)
- Dr. Peterson has a combined 19 yrs of experience in various business development and scientific advisory and management roles in the biopharmaceutical, cell & Gene, and Radiopharmaceutical fields of precision oncology. His expertise focuses on commercialization of cutting-edge therapeutics from discovery, to venture establishment, through to commercial approval and launch. Dr. Peterson’s unique strength centers upon cGMP manufacturing, process development, and Chemistry Manufacturing Controls (CMC) activities.
- Dr. Peterson graduated with a Doctorate degree in Neuroscience from the Faculty of Health Sciences, Department of Medicine, McMaster University and obtained his MBA from the Goodman School of Business.
Francisco Gras, MBA, MAC
Chief Financial Officer
- Strategic senior financial executive with over 20 years of global experience.
- He uses financial management to drive operational and organizational performance.
- Achieves revenue and EBITDA targets for growth companies and major enterprises.
- Former serial CFO, VP of Finance, and Controller at organizations such as:
- Schlumberger
- Atos
- Geokinetics
- Axxis Geo Solutions
- Earned a Master of Accounting at the University of North Carolina, Chapel Hill.
- Holds an MBA from Baylor University.
Izabela Tworowska, Ph.D, MS.Pharm
Chief Scientific Officer Co-Founder & Board Member
- M.S.Pharm (Clinical), Medical University, Poland
- Ph.D. (Chemistry), Centre of Molecular and Macromolecular Studies, Polish Academy of Science
- J.W. Goethe Frankfurt University, Germany
- William Rice Fellowship (Biochemistry), Rice University (Houston)
• +25 years experience in the clinical pharmacy and chemistry
• +13 years experience in oncology research
• International awards: IUPAC and Sigma Aldrich Award
• Expertise: CMC and pre-clinical evaluation of radiotheranostics drugs ( 4 INDs )
• Principal Investigator: 5 SBIR Phase I/II awards
• Co-author of +30 peer-review papers
• Member NIH/NCI study section and Leader AlphaMedix project
Ayda Delpassand, MSRS, MSGM
Director of Quality Assurance and Regulatory Affairs
- MS (Regulatory Science) USC Los Angeles
- MS (Global Medicine), USC Los Angeles
- BS (Biology) SDSU San Diego
• Strategic and regulatory support of INDs and DMF
• Strategic planning for CMC, Non-Clinical, Clinical, Pharmacology, Drug Safety,
Clinical Operations, Data Management, Biostatistics and Medical Writing to
support FDA submissions
• Experienced in Regulatory Operations to ensure quality of submissions meet FDA standard
